Travolta, Preston issue statement about son's death Jan 5, 2009
Travolta, Preston issue statement about son's death -- chicagotribune. Travolta, Preston issue statement about son's death. (Chicago Tribune)
GCS to pump in Rs 722 cr to upgrade Cancer Hospital Jan 4, 2009
The GCS board headed by the Governor of Gujarat, Naval Kishore Sharma, also approved Rs 20 crore for development plan for the Community Oncology Centre and Cancer Exhibition, in the Vasna area of the city. Sharma, while talking to the media after the board meeting said that development plan for community center is expected to be completed by 2010, when Gujarat would celebrate 50 years of its existance as a seperate state. (Economic Times)
Weakened RNA Interference Reduces Survival In Ovarian Cancer Jan 3, 2009
"Dicer and Drosha are crucial for two types of RNA interference, which cells use to shut down genes. We've found that when this machinery is disrupted, patient outcomes are poor," said senior author Anil Sood, M.D., professor in the departments of Gynecologic Oncology and Cancer Biology at M. D. Anderson ... "This suggests that for therapeutic purposes, siRNA might be the better option as we develop new treatments based on interfering RNA," said co-author Robert Coleman, M.D., professor of... (Science Daily)
Trying to prevent lymphedema after breast cancer Jan 3, 2009
A surprising study published in November's Journal of Clinical Oncology suggests few such women may be diagnosed. University of Minnesota researchers analyzed records from the huge Iowa Women's Health study, to cull more than 1,200 patients who'd had breast cancer between 1986 and 2003. (Yahoo News)
Family history of prostate cancer does not affect some treatment outcomes Jan 3, 2009
In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, according to a January 1 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation... (EurekAlert!)
Help for lymphedema after breast cancer Jan 2, 2009
It's been estimated to affect between 20 percent and 30 percent of patients who have 10 or more under-the-arm nodes examined, called an "axillary lymph node dissection." A surprising study published in November's Journal of Clinical Oncology suggests few such women may be diagnosed. University of Minnesota researchers analyzed records from the huge Iowa Women's Health study, to cull more than 1,200 patients who'd had breast cancer between 1986 and 2003. (Montana Standard, MT)
Cancer drug reverses transplant rejection: study Jan 2, 2009
"We are pleased to see its toxicities are similar in transplant recipients suffering from treatment-resistant mixed organ rejection," said study co-author Jason Everly, an oncology pharmacist at the University of Cincinnati. "We hope it will be a viable therapeutic treatment option in this patient group.". (Yahoo News -- Pharmaceutical Industry News)
Letters to the editor (Jan. 2) Jan 2, 2009
I have watched the introduction of oncology to Corvallis by David Kliewer in the 1960s and steady progress by our excellent medical and radiation oncologists. Our hospital has a superb Continuing Medical Education program, and our staff maintains contact with research centers worldwide and monitors the literature carefully. (Corvallis Gazette Times, OR)
Small Molecules, Large Effect: How Cancer Cells Ensure Their Survival Jan 1, 2009
"This new molecular understanding of the defense mechanisms of cancer cells now allows us to focus on these defensive mechanisms," reports Professor Roland Stauber, head of the Department of Molecular and Cellular Oncology. The results of tests conducted on cultured cancer cells within the framework of this study have been promising, as they have shown that the combined use of chemical iNOS inhibitors and a blockade of survivin synthesis can efficiently kill off tumor cells. (Science Daily)
Camp Good Days Sang in New Year Jan 1, 2009
"To live another year I guess, Sharon Courtney of North Cohoctan said. New year wishes are clear to some. It couldn't be any clearer for Camp Good Days and Special Times Founder Gary Mervis. "I'm going to offer my wish that hopefully we can find some answers that have been eluding us on the war on cancer," Mervis said. It's that wish that brought Lynne Stiefler out in the New Year's Eve's bitter cold. "I'm a pediatric oncology nurse. I work at Strong Memorial and I just see the benefits of... (R News)
Radiation Therapy after Breast-Conserving Surgery Jan 1, 2009
From the Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston. Address reprint requests to Dr. Buchholz at the Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 97, Houston, TX 77030, or at tbuchhol@mdanderson. (New England Journal of Medicine)
A Syndrome with Congenital Neutropenia and Mutations in G6PC3 Jan 1, 2009
Address reprint requests to Dr. Klein at the Department of Pediatric Hematology and Oncology, Medical School Hannover, Carl-Neuberg-Stra. e 1, Hannover D-30625, Germany, or at klein. (New England Journal of Medicine)
The Many Causes of Severe Congenital Neutropenia Jan 1, 2009
Dr. Link is an associate professor of medicine, Division of Oncology, Section of Stem Cell Biology, Washington University, St. Louis. . (New England Journal of Medicine)
Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009 Dec 31, 2008
A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. (PR Newswire)
Scantek Medical Files for Chapter 11 Voluntary Bankruptcy and Receives Orders for the Sale of BreastCare(TM) Dec 31, 2008
In clinical studies in the United States (Memorial Sloan Kettering Cancer Center - NY, M.D. Anderson Cancer Center - Houston, Guttman Institute - NY, Georgetown University, and Brotman - UCLA), in Brazil, and at the European Institute of Oncology in Milan, Italy, BreastCare has been clinically proven capable of recognizing metabolic activity (angiogenesis) by recording the heat differentiation of corresponding areas of the breast, and has identified tumors as small as 5 mm in diameter. Scantek... (PR Newswire)
Breast Cancer: Diet High In Vegetables, Fruit And Fiber May Cut Risk Of Cancer Recurrence In Women Without Hot Flashes Dec 31, 2008
The study team, led by researchers at the Moores Cancer Center at the University of California, San Diego, along with six other sites, including the University of California, Davis, reported its results online December 15, 2008, in the Journal of Clinical Oncology. The results come on the heels of a report last year on the findings of the original study, the Women's Healthy Eating and Living Trial (WHEL), which compared the effects of the two diets on cancer recurrence in more than 3,000... (Science Daily)
Ambrilia Biopharma Submits a Request for Arbitration Against Merck Dec 31, 2008
Ambrilia's product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a therapeutic peptide for prostate cancer, a targeted delivery technology for cancer, an HIV protease inhibitor program (exclusive worldwide rights granted to Merck & Co., Inc.) as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. Ambrilia's head office, research and development and... (CCNMatthews Press Releases)
Texaco's Toxic Past in Amazon Haunts Chevron as $27 Billion Judgment Looms Dec 31, 2008
There are enough cancer cases in the Amazon to show there is a trend, and the trend is rising, says Rena Munoz, the doctor in charge of clinical oncology at Sociedad de Lucha Contra el Cancer, the Quito cancer hospital known as that has treated people from the area ... Barba sits at her desk at Baca Ortiz, where she runs the oncology and hematology department, reviewing Dianas records. (Bloomberg)
Errors involving medications common in outpatient cancer treatment Dec 31, 2008
Seven percent of adults and 19 percent of children taking chemotherapy drugs in outpatient clinics or at home were given the wrong dose or experienced other mistakes involving their medications, according to a new study led by Kathleen E. Walsh, MD, assistant professor of pediatrics at the University of Massachusetts Medical School, and published in the January 1, 2009 issue of the Journal of Clinical Oncology ... An analysis of data on nearly 1,300 patient visits at three adult oncology... (EurekAlert!)
A new light on the anti-tumor mechanisms of Scutellaria barbata Dec 31, 2008
Correspondence to: Dr. Zhi-Jun Dai, Department of Oncology, the Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, No. 157, West 5th Road, Xi'an 710004, Shaanxi Province, China. About World Journal of Gastroenterology. (EurekAlert!)
Dr. JoAnne Whitaker Dec 31, 2008
Dr. Whitaker had fellowship programs in pediatric, hematology, oncology, nutrition, and psychiatry, and taught in seven different medical schools. Her work as a doctor, researcher, and instructor took her all over the country, including places such as Sloan-Kettering and Bellevue hospitals (New York), Cincinnati Children s Hospital and Parkland Memorial Hospital, and Children s Medical Center in Dallas, Texas. (The Fort Meade Leader, FL)
USP professor: Ive never seen such a sea change in Big Pharma Dec 30, 2008
Cephalon entered the oncology market in March when the Food and Drug Administration approved Treanda, first as a treatment for leukemia and, last month, for patients with non-Hodgkins Lymphoma. In September, the company agreed to pay the government $425 million to settle charges that it promoted three of its drugs for off-label uses that were not approved by the FDA.. (Philadelphia Business Journal, PA)
Wrestling bulging arms after breast cancer Dec 30, 2008
A surprising study published in November's Journal of Clinical Oncology suggests few such women may be diagnosed. University of Minnesota researchers analyzed records from the huge Iowa Women's Health study, to cull more than 1,200 patients who'd had breast cancer between 1986 and 2003. (MSNBC -- Health)
Help for lymphedema after breast cancer Dec 30, 2008
It's been estimated to affect between 20 percent and 30 percent of patients who have 10 or more under-the-arm nodes examined, called an "axillary lymph node dissection." A surprising study published in November's Journal of Clinical Oncology suggests few such women may be diagnosed. University of Minnesota researchers analyzed records from the huge Iowa Women's Health study, to cull more than 1,200 patients who'd had breast cancer between 1986 and 2003. (Montana Standard, MT)
Recession Anxiety Believed Spreading to Dogs and Cats, Owners' Glum Faces Blamed; Here's How to Calm Your Pet Dec 30, 2008
Specialty services include: Cardiology, Clinical Pathology, Internal Medicine, Oncology, Ophthalmology, Radiology, Surgery and Client Support. The hospital also offers 24 hour emergency care. (Yahoo News -- Press Releases)
News highlights Dec 30, 2008
Transmed Oncology Inc. has optioned two cancer therapies. One is believed to have potential in suppressing cancer growth. (OregonLive, OR -- Business)
Cancer drug reverses transplant rejection: study Dec 30, 2008
"We are pleased to see its toxicities are similar in transplant recipients suffering from treatment-resistant mixed organ rejection," said study co-author Jason Everly, an oncology pharmacist at the University of Cincinnati. "We hope it will be a viable therapeutic treatment option in this patient group.". (Yahoo News -- Pharmaceutical Industry News)
Dr. Zakhary recognized for service Dec 30, 2008
The board also approved the following as recommended by Dr. Zakhary: Initial Appointment of Courtesy Staff; Nadim F. Nimeh, MD Oncology; Manal L. Robin-Hanna, MD Oncology; Dale B. Smith, DO ENT; John H. McGath, DO ENT; Reappointments of James J. Newman, MD Radiology, Active Staff and Richard W. Schafer, DO Family Medicine, Courtesy Staff. Financials for the month of November ended with a net income of $28,655 and year-to-date net income of $685,863. (Altus Times, OK)
Cancer Drug May Help With Kidney Transplants Dec 30, 2008
The toxicities of bortezomib were at expected and manageable levels that were less than those of other anti-cancer agents, study co-author Jason Everly, an oncology pharmacist in the division of transplant surgery at UC, said in the same news release. More information. (Washington Post)
WNYers make hockey hot list Dec 30, 2008
- New York Oncology Hematology. - New York Oncology Hematology ... - New York Oncology Hematology. (Buffalo Business First, NY)
Minimizing obesity's impact on ovarian cancer survival Dec 30, 2008
The results are published online in the journal Gynecologic Oncology ... The Gynecologic Oncology study was collaboration between UAB's Division of Gynecologic Oncology, the Division of Hematology/Oncology and the University of South Alabama's Mitchell Cancer Institute in Mobile. (EurekAlert!)
Safe new therapy for genetic heart disease Dec 30, 2008
The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, or the description or polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods for diagnosis or monitoring of disease or disease predisposition. . (EurekAlert!)
Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone Dec 28, 2008
Journal Medicinal Food 2008 Dec; 11:773-83; Translational Oncology 2008 March; 1:19-27; Life Science 2008 May 7; 82: 1032-9. Sardi says longevity seekers often demand human lifespan studies, not realizing such a study would be impractical, taking 100 years to complete. (PR Newswire)
New Anti-cancer Components Of Extra-virgin Olive Oil Revealed Dec 28, 2008
Javier Menendez from the Catalan Institute of Oncology and Antonio Segura-Carretero from the University of Granada in Spain led a team of researchers who set out to investigate which parts of olive oil were most active against cancer. Menendez said, Our findings reveal for the first time that all the major complex phenols present in extra-virgin olive oil drastically suppress overexpression of the cancer gene HER2 in human breast cancer cells. (Science Daily)
Cancer drug effectively treats transplant rejections Dec 28, 2008
Jason Everly, a board-certified oncology pharmacist in the division of transplant surgery at UC and co-author of the study, says the toxicities associated with this drug were predictable and manageable and were much less than those associated with other anti-cancer agents. "We are pleased to see its toxicities are similar in transplant recipients suffering from treatment-resistant mixed organ rejection," he adds. (EurekAlert!)
On the Move With a New Breast Cancer Resource Dec 26, 2008
HER Move was funded and developed by GlaxoSmithKline Oncology. Courtesy of ARAcontent. (Pekin Times, IL)
Two women use positive attitude, friendship to weather cancer Dec 26, 2008
Clementine Ross and Selma Biart pose at Rocky Mountain Oncology Center on Tuesday in Casper ... Biart sat in the corner of the chemotherapy room at Rocky Mountain Oncology Center receiving her treatment when Ross entered the room moaning and groaning loudly ... "The good news, the very best, is the people I meet at oncology," Ross said. (Casper Star-Tribune)
The American Nurses Association on Behalf of the Larger Nursing Community Announces the Release of a First of Its Kind Study on the Economic Value of Nursing Dec 26, 2008
"Nurses are a vital component to the health care system," said ANA President Rebecca M. Patton, MSN, RN, CNOR. "This nursing funded study provides a model that shows how nurses affect the delivery of cost-effective, high quality care, and prevent adverse events. This project was the culmination of years of research that could not have been possible without the tireless work and cooperation of The American Association of Critical Care Nurses, the American Association of Colleges of Nursing, the... (PR Newswire)
Post-Cancer Reproduction Still Low for Women, Men Dec 26, 2008
"There is much left to be done to improve post-diagnosis reproduction, in particular in women," Dr. Sophie Dorothea Fossa of The Norwegian Radium Hospital in Oslo and her colleagues conclude in a report in the Journal of Clinical Oncology ... SOURCE: Journal of Clinical Oncology, online December 15, 2008. (MEDLINEplus)
Tau Protein Expression Predicts Breast Cancer Survival -- Though Not As Expected Dec 26, 2008
"If you treat patients who have a low level of Tau protein expression with pre-operative chemotherapy in neo-adjuvant studies, they are very likely to have a good response to the chemotherapy," said Lajos Pusztai, M.D., D. Phil, associate professor of medicine in the Department of Breast Medical Oncology at M. D. Anderson and the study's first author ... In addition to Pusztai, other M. D. Anderson co-authors include: Gabriel N. Hortobagyi, M.D., professor and chair, Department of Breast Medical... (Science Daily)
Combo treatment for prostate cancer cuts deaths Dec 26, 2008
"What this study shows is that men with prostate cancer do benefit from more aggressive therapy," said Dr. Howard Sandler, of Cedars-Sinai Medical Center in Los Angeles and a spokesman for the American Society of Clinical Oncology. The Scandinavian rearchers tracked 875 men with advanced prostate cancer in Denmark, Norway and Sweden. (Chippewa Falls Chippewa Herald, WI)
Combo treatment for prostate cancer cuts deaths Dec 26, 2008
"What this study shows is that men with prostate cancer do benefit from more aggressive therapy," said Dr. Howard Sandler, of Cedars-Sinai Medical Center in Los Angeles and a spokesman for the American Society of Clinical Oncology. The Scandinavian researchers tracked 875 men with advanced prostate cancer in Denmark, Norway and Sweden. (North County Times)
Cytokinetics Retains Development and Commercialization Rights to Ispinesib and SB-743921 Dec 25, 2008
"The seven year collaboration between Cytokinetics and GSK has generated three novel drug candidates now in clinical development," said Paolo Paoletti, MD Senior Vice President of GSK Oncology R&D. "The decision by GSK to not exercise options on ispinesib and SB-743921 was the result of a shift in portfolio direction for GSK. We continue to believe that the novel mechanism of anti-mitotics may bring hope to cancer patients, reflected in GSK's ongoing development of GSK-923295 under its... (PR Newswire)
Rules Change Could Increase Hospice Use Dec 25, 2008
Casarett and his colleagues interviewed 283 people receiving cancer treatment at six oncology centers in the University of Pennsylvania Cancer Network, asking them about their perceived need for five hospice services and their preferences for continued cancer treatment. They concentrated on blacks, since statistics show they are less likely to seek hospice care. (MEDLINEplus)
Early Stage, HER2-positive Breast Cancer Patients At Increased Risk Of Recurrence Dec 25, 2008
The findings, presented today at the CRTC-AACR San Antonio Breast Cancer Symposium, is the first large study to analyze this cohort and represents a shift in the way women with early-stage HER2 positive breast cancer should be assessed for risk of recurrence and considered for treatment, said the study's senior author, Ana M. Gonzalez-Angulo, M.D, assistant professor in M. D. Anderson's Department of Breast Medical Oncology and Systems Biology ... " For the retrospective study, Gonzalez-Angulo,... (Science Daily)
Tumor Suppressor Gene: Gene Function 'Lost' In Melanoma And Glioblastoma Dec 25, 2008
"Over the past decade several dozen tumor suppressor genes have been identified, but only a minority of them is important in causing many different tumor types. PTPRD seems to be one of these broad spectrum tumor suppressor genes," says the study's lead investigator, Todd Waldman, MD, PhD, an associate professor of oncology at Georgetown's Lombardi Comprehensive Cancer Center. If the hypothesis is true and Waldman and his team are now investigating loss of PTPRD in a number of additional cancers... (Science Daily)
Hormone Therapy For Prostate Cancer Does Not Appear To Increase Cardiac Deaths Dec 25, 2008
In their Journal of Clinical Oncology report, which has been released online, the researchers note that GnRH agonist treatment has a number of adverse side effects, which should be kept in mind when determining treatment strategies. "Hormonal therapy for prostate cancer has become routine for many patients, so it's even more important to understand the potential adverse effects of treatment," says lead author Jason Efstathiou, MD, PhD, of the MGH Cancer Center. (Science Daily)
How to tell your child, 'You're really sick' Dec 23, 2008
Very young children might think they did something to cause cancer, according to the American Society of Clinical Oncology, and need to be reassured this isn't the case. But often children this age aren't focused on the illness, Wolfe said. (CNN -- Health)
'Serious' clowns distract patients from their pain Dec 23, 2008
She also teaches an oncology class to the Lev Leytzan clowns. "It adds another dimension to their training and gives them an overview and an understanding to know what it's like to be a kid with cancer," she said. (CNN -- Health)
Can Olive Oil Kill Breast Cancer? Dec 23, 2008
A team of researchers from the Catalan Institute of Oncology and the University of Granada said that phenols found in extra-virgin olive oil stop a gene called HER2 that causes breast cancer. Other kinds of olive oil lose the beneficial substances when they are treated with heat, according to a news release about the work. (Click2Houston, TX)
FDA warnings for 30 diet drugs Dec 23, 2008
The Food and Drug Administration on Monday warned people to avoid nearly 30 weight-loss products that contain unlisted and possibly dangerous ingredients. They may promise an easy fix to weight problems, but the FDA said they contain unlisted ingredients, including high doses of a powerful anti-obesity drug, as well as a suspected carcinogen. (Chicago Tribune)
Protein Levels Indicate Risk Of Death In Some Colorectal Cancer Patients Dec 23, 2008
Journal of Clinical Oncology, Dec 8, 2008. Adapted from materials provided by , via , a service of AAAS. Email or share this story. (Science Daily)
Cool Kailua Nights moves from February to October 2009 Dec 23, 2008
Castle Medical Center's Oncology Clinic provides a variety of outpatient services for patients battling cancer ... Cool Kailua Nights Founder Danielle Scherman designates a portion of the proceeds from the block party to benefit Castle's Oncology Clinic, where her mother received invaluable treatment. (Honolulu Advertiser)
Getting ahead Dec 23, 2008
The following are new members of the Missoula Area Chamber of Commerce: ADT Security Services, Bitter Root Acupuncture rium, Bitterroot River Inn rence Center, Campus Inn, Clark Industrial Inc., DQ Grill , Flathead Travel Service Inc., Guardian Oncology r for Wellness, Montana Spirited Massage - Heather Starkey and Skin Essentials. Name. (Missoulian, MT)
Closures, cancellations Dec 23, 2008
Kaiser Permanente's Radiation Oncology Center on the Interstate campus will also be open. Kaiser Permanente's administrative buildings will be open as well. (Longview Daily News, WA)
Purchase of AviaraDx positions bioMerieux for cancer care niche Dec 23, 2008
The diagnostic products made at both the Durham and St. Louis facilities, as well as the oncology tests from AviaraDx, are marketed globally. Steward says he expects employment levels, including staffing at AviaraDx, to hold steady in North America. (Triangle Business Journal)
Olive Oil Fights Breast Cancer Dec 23, 2008
Our findings reveal for the first time that all the major complex phenols present in extra-virgin olive oil drastically suppress overexpression of the cancer gene HER2 in human breast cancer cells, wrote study authors Javier Menndez from the Catalan Institute of Oncology and Antonio Segura-Carretero from the University of Granada. Extra-virgin olive oil is derived from pressing olives without heat or chemicals. (Newsmax)
Obese people at risk of cancer death Dec 23, 2008
As part of their study, the researchers, led by oncology professor Vickie Baracos, viewed computed tomography images of 250 obese cancer patients, a university release said Monday ... The study has been published in Lancet Oncology. (India Times, India)
Prostrakan and Paladin Complete Agreement for Abstral(R) and Sancuso(R) Dec 22, 2008
"It is our intention to submit these two innovative products for Canadian regulatory approval in mid-2009. We expect Abstral and Sancuso to fulfill an unmet need for cancer patients in Canada," said Jonathan Ross Goodman, President and Chief Executive Officer of Paladin Labs Inc. "These products complement our dynamic and growing promoted pain portfolio, which already includes Tridural(TM), Metadol and Pennsaid, and provides us an additional pillar upon which to build out a supportive care... (CCNMatthews Press Releases)
Glaxo to buy Bristol-Myers Squibb Pakistan Dec 22, 2008
The London-based drug maker said that BMS Pakistan's product portfolio, which includes antibiotics, vitamins and dermatology products is complementary to its existing portfolio and will also provide opportunities in the fast-growing therapeutic areas of cardiovascular and oncology. Total sales of the BMS Pakistan's product portfolio in 2007 were PKR1. (Atlanta Journal-Constitution -- Business)
Progen, Avexa agree to merge Dec 22, 2008
"This merger will create a leading Australian biotech company with expertise in two major indications, oncology and infectious diseases," Mr Droma said. But shareholders in both companies appeared unconvinced on the merits of the deal, wiping 11% off the value of Progen shares and 23% off Avexa's value after the deal was announced. (The Age)
How olive oil can help fight breast cancer Dec 22, 2008
Javier Menendez from the Catalan Institute of Oncology and Antonio Segura-Carretero from the University of Granada in Spain led a team of researchers who set out to investigate which parts of olive oil were most active against cancer. Menendez said, Our findings reveal for the first time that all the major complex phenols present in extra-virgin olive oil drastically suppress overexpression of the cancer gene HER2 in human breast cancer cells. (Thaindian.com)
Mutations common to cancer and developmental disorder examined in a novel disease model Dec 22, 2008
The report was written by Cristiana Santoriello, Gianluca Deflorian, Federica Pezzimenti, Luisa Lanfrancone, Fabrizio d'Adda di Fagagna and Marina Mione of the European Institute of Oncology and the FIRC Institute for Molecular Oncology Foundation in Milan, Italy, and Koichi Kawakami of the National Institute of Genetics, Mishima, Shizuoka, Japan. The report is published in the January/February issue of a new research journal, Disease Models nisms (DMM), published by The Company of Biologists, a... (EurekAlert!)
Eligibility criteria contribute to racial disparities in hospice use Dec 22, 2008
To define and compare preferences for cancer treatment and perceived needs for hospice services among African-American patients and white patients, Dr. David Casarett and colleagues interviewed 283 patients who were receiving cancer treatment at six oncology clinics within the University of Pennsylvania Cancer Network. Patients were asked about their perceived need for five hospice services and their preferences for continuing cancer treatment, and they were followed for six months or until... (EurekAlert!)
Newly identified gene powerful predictor of colon cancer metastasis Dec 22, 2008
1 Max Delbrck Center for Molecular Medicine, Robert RssleStrasse 10, 13125 Berlin, Germany 2 Department of Surgery and Surgical Oncology, Robert Rssle Cancer Hospital Charit University Medicine Berlin, Lindenberger Weg 80, 13125 Berlin, Germany. Barbara Bachtler Press and Public Affairs Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch Robert-Rssle-Strae 10; 13125 Berlin; Germany Phone: +49 (0) 30 94 06 - 38 96 Fax: +49 (0) 30 94 06 - 38 33 e-mail. (EurekAlert!)
